L57.0 C44.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Actinic keratosis, cutaneous squamous cell carcinoma and basalioma 2) treatment of one of the three diagnoses between Apr 1st 2007 and July 1st 2020 3) age =18 years 4) legal capacity 5) voluntarily and written informed consent before the start of documentation 6) treatment with mistletoe resin cream in the relevant period of time
Exclusion criteria
Exclusion criteria: 1) Indications other than those mentioned above that have led to therapy with mistletoe resin cream 2) Use of another topical treatment or participation in another clinical trial during the treatment period with mistletoe resin cream or four weeks before 3) Clinically relevant concomitant conditions that excessively restrict the assessment of the effect and the tolerability of the mistletoe resin cream
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic effect: - clinical response according to RECIST at the last documented date Safety and tolerability : - incidence, frequency and severity of adverse drug reactions according to CTCAE V5 over the whole documented course of therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| - Clinical response rate according to RECIST (complete or partial remission) at the last documented time - time from the start of therapy to best clinical response - cosmetic result from the treating physician`s point of view - patient satisfaction from the treating physician`s point of view - descriptive representation of typical/ unfavourable/ favourable courses | — |
Countries
Austria, Germany, Switzerland
Contacts
Lehrstuhl für Medizintheorie, Integrative und Anthroposophische MedizinUniversität Witten/Herdecke